Post-marketing surveillance in Japan: Potential best way forward

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1138-1139. doi: 10.1002/pds.4290.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drugs, Investigational / adverse effects*
  • Humans
  • Japan
  • Product Surveillance, Postmarketing / trends*

Substances

  • Drugs, Investigational